Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for pain and recovery after thoracoscopic lung resection
ChiCTR2100042239Phase 4Recruiting
- Sponsor
- Jinling Hospital
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of esketamine in postoperative pain (2 arms), sponsored by Jinling Hospital. Primary endpoints: Pain visual analogue scale (VAS) and Recovery quality score. Started Feb 2021; status: recruiting.
02
Drugs
esketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2100042239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042239.